Jim Simons Acrivon Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

  • $70.6 Billion
  • Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 623,400 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
623,400
Previous 509,295 22.4%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
N/A
114,105 Added 22.4%
623,400 $0
Q2 2025

Aug 13, 2025
BUY
N/A
457,195 Added 877.53%
509,295 $0
Q1 2025

May 14, 2025
BUY
N/A
2,700 Added 5.47%
52,100 $0
Q4 2024

Feb 13, 2025
BUY
N/A
3,500 Added 7.63%
49,400 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-8,600 Reduced 15.78%
45,900 $0
Q2 2024

Aug 09, 2024
SELL
N/A
-48,100 Reduced 46.88%
54,500 $0
Q1 2024

May 13, 2024
BUY
N/A
102,600 New
102,600 $734,000

Others Institutions Holding ACRV

# of Institutions
47
Shares Held
18.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email